SCHEMBL27906302

SCHEMBL27906302

Clc1ccnn1-c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.57
NPC1 O15118 4/20 0.44
RAB9A P51151 4/20 0.44
HTT P42858 4/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
ALDH1A1 P00352 3/20 0.44
MAPT P10636 2/20 0.44
MITF O75030 1/20 0.44
S1PR4 O95977 1/20 0.44
THRB P10828 1/20 0.44
XBP1 P17861 1/20 0.44
S1PR1 P21453 1/20 0.44
PAX8 Q06710 1/20 0.44
CYP2C9 P11712 7/20 0.43
GAA P10253 1/20 0.43
MDM2 Q00987 1/20 0.41
LMNA P02545 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27822210 0.78 OXTR (0.48) POLBALDH1A1KDM4EMEN1KMT2A
SCHEMBL24185602 0.78 NPBWR1 (0.40) POLBNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL2555958 0.77 NPBWR1 (0.45) POLBALDH1A1MAPTMEN1KMT2A
SCHEMBL10446383 0.75 RAB9A (0.61) POLBNPC1RAB9AHTTSMN1; SMN2
SCHEMBL17227421 0.73 POLB (0.57) POLBNPC1RAB9AHTTSMN1; SMN2
SCHEMBL411379 0.73 POLB (0.57) POLBNPC1RAB9AHTTSMN1; SMN2
SCHEMBL5318677 0.73 POLB (0.57) POLBNPC1RAB9AHTTSMN1; SMN2
SCHEMBL255499 0.73 POLB (0.57) POLBNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL8674209 0.73 POLB (0.57) POLBNPC1RAB9AHTTSMN1; SMN2
SCHEMBL5579308 0.73 POLB (0.57) POLBNPC1RAB9ACYP2C9GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104136399-A Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme MILLENNIUM PHARM INC 2014-11-05 CN claimed
CN-109662961-A For improving the method and composition of cognitive function 约翰斯霍普金斯大学 2019-04-23 CN disclosed
CN-109662964-A For improving the method and composition of cognitive function 约翰斯.霍普金斯大学 2019-04-23 CN disclosed
CN-104136399-B The pyrazolopyrimidine base inhibitor of ubiquitin activating enzyme 米伦纽姆医药公司 2018-08-07 CN disclosed
CN-105142623-A Methods and compositions for improving cognitive function AGENEBIO INC 2015-12-09 CN disclosed
CN-104136399-A Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme MILLENNIUM PHARM INC 2014-11-05 CN disclosed
CN-103476255-A Methods and compositions for improving cognitive function UNIV JOHNS HOPKINS 2013-12-25 CN disclosed
CN-102905532-A Methods and compositions for improving cognitive function UNIV JOHNS HOPKINS 2013-01-30 CN disclosed